These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7541229)

  • 1. (Patho)physiologic pathways to drug targeting: artificial viral envelopes.
    Schreier H; Ausborn M; Günther S; Weissig V; Chander R
    J Mol Recognit; 1995; 8(1-2):59-62. PubMed ID: 7541229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial viral envelopes containing recombinant human immunodeficiency virus (HIV) gp160.
    Chander R; Schreier H
    Life Sci; 1992; 50(7):481-9. PubMed ID: 1371818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of HIV membrane reconstituted from its recombinant gp160 envelope glycoprotein.
    Cornet B; Decroly E; Thines-Sempoux D; Ruysschaert JM; Vandenbranden M
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1823-31. PubMed ID: 1457195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interaction between HIV-1 major envelope glycoprotein and dextran sulfate.
    Mbemba E; Chams V; Gluckman JC; Klatzmann D; Gattegno L
    Biochim Biophys Acta; 1992 Jan; 1138(1):62-7. PubMed ID: 1371075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
    Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing.
    Koga Y; Nakamura K; Sasaki M; Kimura G; Nomoto K
    Virology; 1994 May; 201(1):137-41. PubMed ID: 8178478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
    Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
    J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
    Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
    Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibody.
    Krugner-Higby L; Goff D; Edwards T; Iyer N; Neufeld J; Kute T; Morris-Natschke S; Ishaq K; Piantadosi C; Kucera LS
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):705-12. PubMed ID: 7576930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of HIV-1 gp160-mediated receptor interference: intracellular complex formation.
    Martin RA; Nayak DP
    Virology; 1996 Jun; 220(2):461-72. PubMed ID: 8661396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors.
    Paul NL; Marsh M; McKeating JA; Schulz TF; Liljeström P; Garoff H; Weiss RA
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):963-70. PubMed ID: 8280479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
    Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
    Fenouillet E; Gluckman JC
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 of HIV-1 or infected with HIV-1.
    Keay S; Tacket CO; Murphy JR; Handwerger BS
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1091-8. PubMed ID: 1503823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4.
    Andersen O; Sørensen AM; Svehag SE; Fenouillet E
    Scand J Immunol; 1991 Jan; 33(1):81-8. PubMed ID: 1996409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.
    Pincus SH; Messer KG; Schwartz DH; Lewis GK; Graham BS; Blattner WA; Fisher G
    J Clin Invest; 1993 May; 91(5):1987-96. PubMed ID: 7683694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mutations in constant regions 3 and 4 of envelope of simian immunodeficiency virus.
    Morrison HG; Kirchhoff F; Desrosiers RC
    Virology; 1995 Jul; 210(2):448-55. PubMed ID: 7618279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.